These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 7636198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice.
    Kobayashi H, Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki F.
    J Immunol; 1999 Jun 15; 162(12):7148-54. PubMed ID: 10358160
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice.
    Ghiasi H, Osorio Y, Perng GC, Nesburn AB, Wechsler SL.
    J Virol; 2001 Oct 15; 75(19):9029-36. PubMed ID: 11533166
    [Abstract] [Full Text] [Related]

  • 7. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.
    Cell Immunol; 1996 May 25; 170(1):41-53. PubMed ID: 8660798
    [Abstract] [Full Text] [Related]

  • 8. Influence of type 2 T cell responses on the severity of encephalitis associated with influenza virus infection.
    Kaji M, Kobayashi M, Pollard RB, Suzuki F.
    J Leukoc Biol; 2000 Aug 25; 68(2):180-6. PubMed ID: 10947061
    [Abstract] [Full Text] [Related]

  • 9. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
    von der Weid T, Beebe AM, Roopenian DC, Coffman RL.
    J Immunol; 1996 Nov 15; 157(10):4421-7. PubMed ID: 8906817
    [Abstract] [Full Text] [Related]

  • 10. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM, Dempsey D, Wolcott RM, Chervenak R, Jennings SR.
    J Immunol; 1999 Jul 15; 163(2):675-81. PubMed ID: 10395657
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoids produced during exercise may be necessary for optimal virus-induced IL-2 and cell proliferation whereas both catecholamines and glucocorticoids may be required for adequate immune defense to viral infection.
    Kohut ML, Martin AE, Senchina DS, Lee W.
    Brain Behav Immun; 2005 Sep 15; 19(5):423-35. PubMed ID: 15935613
    [Abstract] [Full Text] [Related]

  • 12. Herpes simplex encephalitis.
    Sköldenberg B.
    Scand J Infect Dis Suppl; 1996 Sep 15; 100():8-13. PubMed ID: 9163027
    [Abstract] [Full Text] [Related]

  • 13. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
    Ghiasi H, Cai S, Slanina SM, Perng GC, Nesburn AB, Wechsler SL.
    J Infect Dis; 1999 May 15; 179(5):1086-93. PubMed ID: 10191208
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
    Peltoniemi J, Broberg EK, Nygårdas M, Erälinna JP, Waris M, Hukkanen V.
    Int Immunopharmacol; 2006 May 15; 6(5):817-29. PubMed ID: 16546713
    [Abstract] [Full Text] [Related]

  • 15. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
    Tolo FM, Rukunga GM, Muli FW, Njagi EN, Njue W, Kumon K, Mungai GM, Muthaura CN, Muli JM, Keter LK, Oishi E, Kofi-Tsekpo MW.
    J Ethnopharmacol; 2006 Mar 08; 104(1-2):92-9. PubMed ID: 16198524
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulatory roles of topical dinitrochlorobenzene treatment in Herpes simplex virus infection.
    Yamaji M, Shudo J.
    Int Immunopharmacol; 2009 Jul 01; 9(7-8):984-9. PubMed ID: 19362169
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin-3 protects mice from acute herpes simplex virus infection.
    Chan WL, Ziltener HJ, Liew FY.
    Immunology; 1990 Nov 01; 71(3):358-63. PubMed ID: 2176641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.